InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Harford Simon N.R., Chief Financial Officer. Director active across 2 companies, notably Albireo Pharma, INC.. In total, 23 disclosures have been published. Breakdown: 0 buy · 12 sells. Total volume traded: €108k. History available since 13 July 2021. The latest transaction was disclosed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Harford Simon N.R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
143,595 shares@ US$14.500.045% mcap62.5% of flowCommon StockSEC:0001193125-26-182244:0
71,303 shares@ US$14.2580.9% of flowCommon StockSEC:0001193125-25-337337:0
12,529 shares@ US$7.602.8% of flowCommon StockSEC:0001443705-25-000004:0
7,482 shares@ US$9.316.3% of flowCommon StockSEC:0000950170-25-002421:0
12,529 shares@ US$12.0912.7% of flowCommon StockSEC:0000950170-24-100253:0
57,392 shares0Common StockSEC:0000950170-24-002094:0
106,973 shares0Common StockSEC:0001209191-23-047104:0
13,739 sharesCommon StockSEC:0001209191-23-014786:0
55,000 shares0Common StockSEC:0001209191-23-005333:0
55,000 shares0Common StockSEC:0001209191-23-004948:0
102 shares@ US$43.803.3% of flowCommon StockSEC:0001209191-23-004453:0
1,776 shares@ US$43.8057.5% of flowCommon StockSEC:0001209191-23-004219:0
104 shares@ US$19.57641.6% of flowCommon StockSEC:0001209191-22-054487:0
80 shares@ US$23.78581.6% of flowCommon StockSEC:0001209191-22-053556:0
106 shares@ US$24.67132.0% of flowCommon StockSEC:0001209191-22-043106:0
95 shares@ US$24.02761.8% of flowCommon StockSEC:0001209191-22-042038:0
103 shares@ US$32.92472.9% of flowCommon StockSEC:0001209191-22-025525:0
96 shares@ US$35.74392.9% of flowCommon StockSEC:0001209191-22-023974:0
416 shares@ US$24.88228.4% of flowCommon StockSEC:0001209191-22-004807:0
21,600 shares0Common StockSEC:0001209191-22-004063:0
111 shares@ US$25.94642.3% of flowCommon StockSEC:0001209191-22-002923:0
93 shares@ US$30.23392.2% of flowCommon StockSEC:0001209191-21-060216:0
98 shares@ US$35.022.7% of flowCommon StockSEC:0001209191-21-046787:0
23 of 23 declarations
About Harford Simon N.R.
Harford Simon N.R. is Directeur Financier. He is linked to Albireo Pharma, INC. as CFO and Treasurer, and to Amicus Therapeutics, INC. as Chief Financial Officer. His total number of filings is 23. Among the sampled recent filings from 2021-07-15 to 2026-04-27, sales total 1884342 EUR and the modal transaction nature is Cession.
